Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Subsidiaries With Material Non-controlling Interest

v3.22.4
Subsidiaries With Material Non-controlling Interest
12 Months Ended
Dec. 31, 2022
Disclosure of subsidiaries [abstract]  
Subsidiaries With Material Non-controlling Interest

36. Subsidiaries with material non-controlling interest

The Stevanato Group comprises the following subsidiaries with material non-controlling interest:

 

 

 

 

 

At December 31,

 

 

At December 31,

 

Name

 

Country

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

Ompi of Japan Co., Ltd.

 

Japan

 

 

49

%

 

 

49

%

Medical Glass a.s.

 

Slovakia

 

 

0.26

%

 

 

0.26

%

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31,

 

 

At December 31,

 

 

 

 

 

2022

 

 

2021

 

 

 

 

 

(EUR thousand)

 

 

 

 

 

 

 

 

 

 

Proportion of equity interest held by non-controlling interests:

 

 

 

 

 

 

 

 

Ompi of Japan Co., Ltd.

 

 

 

 

451

 

 

 

419

 

Medical Glass a.s.

 

 

 

 

(64

)

 

 

(56

)

 

 

 

 

 

387

 

 

 

363

 

 

 

 

 

 

 

 

 

 

Profit allocated to material non-controlling interest:

 

 

 

 

 

 

 

 

Ompi of Japan Co., Ltd.

 

 

 

 

(176

)

 

 

60

 

Medical Glass a.s.

 

 

 

 

9

 

 

 

(8

)

 

 

 

 

 

(167

)

 

 

52

 

 

Changes in non-controlling interests are shown in the consolidated statement of changes in equity.

The tables below show the summarized income statement for the year ended December 31, 2022:

 

 

 

Ompi of Japan
Co., Ltd.

 

 

Medical Glass a.s.

 

 

 

(EUR thousand)

 

 

 

 

 

 

 

 

Net Sales

 

 

7,059

 

 

 

38,362

 

Cost of Sales

 

 

5,779

 

 

 

37,255

 

Gross Profit

 

 

1,280

 

 

 

1,107

 

 

 

 

 

 

 

 

Other operating income

 

 

 

 

 

42

 

Selling and marketing expenses

 

 

484

 

 

 

46

 

Research and development expenses

 

 

144

 

 

 

 

General and administrative expenses

 

 

126

 

 

 

4,470

 

Operating profit

 

 

526

 

 

 

(3,367

)

 

 

 

 

 

 

 

Interest income

 

 

33

 

 

 

47

 

Interest expense

 

 

45

 

 

 

136

 

Profit before tax

 

 

514

 

 

 

(3,456

)

 

 

 

 

 

 

 

Income taxes

 

 

154

 

 

 

79

 

Net Profit

 

 

360

 

 

 

(3,535

)

 

 

 

 

 

 

 

Total comprehensive income

 

 

388

 

 

 

(3,535

)

 

 

 

 

 

 

 

Attributable to non-controlling interests

 

 

176

 

 

 

(9

)

Dividends paid to non-controlling interests

 

 

 

 

 

 

 

The tables below show the summarized income statement for the year ended December 31, 2021:

 

 

 

Ompi of Japan
Co., Ltd.

 

 

Medical Glass a.s.

 

 

 

(EUR thousand)

 

 

 

 

 

 

 

 

Net Sales

 

 

4,325

 

 

 

41,643

 

Cost of Sales

 

 

3,542

 

 

 

34,425

 

Gross Profit

 

 

783

 

 

 

7,218

 

 

 

 

 

 

 

 

Other operating income

 

 

 

 

 

195

 

Selling and marketing expenses

 

 

299

 

 

 

177

 

Research and development expenses

 

 

150

 

 

 

 

General and administrative expenses

 

 

452

 

 

 

3,302

 

Operating profit

 

 

(118

)

 

 

3,934

 

 

 

 

 

 

 

 

Interest income

 

 

37

 

 

 

111

 

Interest expense

 

 

90

 

 

 

42

 

Profit before tax

 

 

(171

)

 

 

4,003

 

 

 

 

 

 

 

 

Income taxes

 

 

(48

)

 

 

826

 

Net Profit

 

 

(123

)

 

 

3,177

 

 

 

 

 

 

 

 

Total comprehensive income

 

 

(123

)

 

 

3,165

 

 

 

 

 

 

 

 

Attributable to non-controlling interests

 

 

(60

)

 

 

8

 

Dividends paid to non-controlling interests

 

 

 

 

 

 

 

 

The tables below show the summarized income statement for the year ended December 31, 2020:

 

 

 

Ompi of Japan
Co., Ltd.

 

 

Medical Glass a.s.

 

 

 

(EUR thousand)

 

 

 

 

 

 

 

 

Net Sales

 

 

6,811

 

 

 

36,852

 

Cost of Sales

 

 

5,509

 

 

 

30,039

 

Gross Profit

 

 

1,302

 

 

 

6,813

 

 

 

 

 

 

 

 

Other operating income

 

 

 

 

 

43

 

Selling and marketing expenses

 

 

349

 

 

 

165

 

Research and development expenses

 

 

157

 

 

 

 

General and administrative expenses

 

 

518

 

 

 

2,715

 

Operating profit

 

 

278

 

 

 

3,976

 

 

 

 

 

 

 

 

Interest income

 

 

17

 

 

 

2

 

Interest expense

 

 

74

 

 

 

30

 

Profit before tax

 

 

221

 

 

 

3,948

 

 

 

 

 

 

 

 

Income taxes

 

 

66

 

 

 

834

 

Net Profit

 

 

155

 

 

 

3,114

 

 

 

 

 

 

 

 

Total comprehensive income

 

 

155

 

 

 

3,111

 

 

 

 

 

 

 

 

Attributable to non-controlling interests

 

 

76

 

 

 

8

 

Dividends paid to non-controlling interests

 

 

 

 

 

 

 

The tables below show the summarized financial position as at December 31, 2022:

 

 

 

Ompi of Japan
Co., Ltd.

 

 

Medical Glass a.s.

 

 

 

(EUR thousand)

 

 

 

 

 

 

 

 

Property, plant and equipment and other non-current assets

 

 

395

 

 

 

19,102

 

Net working capital

 

 

(92

)

 

 

5,228

 

Total non-current liabilities and provision

 

 

 

 

 

(769

)

Net capital employed

 

 

303

 

 

 

23,561

 

Net financial position*

 

 

(864

)

 

 

(2,306

)

Total equity

 

 

(561

)

 

 

21,255

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

Equity holders of parent

 

 

(286

)

 

 

21,199

 

Non-controlling interest

 

 

(275

)

 

 

55

 

 

*Net financial position is determined as the algebraic sum of cash and cash equivalent, other current financial assets, non-current financial liabilities and current financial liabilities

 

The tables below show the summarized financial position as at December 31, 2021:

 

 

 

Ompi of Japan
Co., Ltd.

 

 

Medical Glass a.s.

 

 

 

(EUR thousand)

 

 

 

 

 

 

 

 

Property, plant and equipment and other non-current assets

 

 

534

 

 

 

13,658

 

Net working capital

 

 

(280

)

 

 

5,582

 

Total non-current liabilities and provision

 

 

 

 

 

(653

)

Net capital employed

 

 

254

 

 

 

18,587

 

Net financial position*

 

 

(1,233

)

 

 

6,204

 

Total equity

 

 

(979

)

 

 

24,791

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

Equity holders of parent

 

 

(500

)

 

 

24,727

 

Non-controlling interest

 

 

(479

)

 

 

64

 

 

*Net financial position is determined as the algebraic sum of cash and cash equivalent, other current financial assets, non-current financial liabilities and current financial liabilities